
Journal

Across the UK, and perhaps the world, leases are not being renewed. Offices are being closed. Millions more of us will be working from home, permanently. This means it will no longer be good enough to approach home working with a make do and mend approach.

Digging deep into the numbers behind the vaccines
We take a look at the different vaccines in play and the data that is circulating about each.

The epidemic of inactivity and how to tackle it
As the nation emerges stiff-limbed and pasty-faced out of what feels like the longest winter ever, it will be time to take stock of our physical condition.

Obesity: Science puts a new drug on the menu
Healthcare, like life, is very much easier when you have options. Being able to pick and choose what remedy might work in particular circumstances both increases the overall chances of success and can provide more elegant and tailored solutions. It’s with this overall philosophy in mind that any new drug should be welcomed to the market. One such drug is semaglutide, a new medication hailed as a ‘game-changer’ in the treatment of obesity.